Andreas W Mattes
CIK 1578706 · View on SEC EDGAR ↗
First SEC filing: Feb. 15, 2018 · Latest: Feb. 15, 2018
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 21, 2017 | DBD | P | 2,000 | $21.90 | $43,800 | 209,590 Direct | +0.96% | Acquired | 207.7% (price as of 2026-08-20) |
| Feb. 11, 2016 | DBD | S 10b5-1 | 3,555 | $23.25 | $82,654 | 137,820 Direct | -2.51% | Disposed | 189.8% (price as of 2026-08-20) |
| June 13, 2014 | DBD | P | 450 | $37.75 | $16,988 | 49,153 Direct | +0.92% | Acquired | 78.5% (price as of 2026-08-20) |
| June 13, 2014 | DBD | P | 550 | $37.77 | $20,774 | 48,703 Direct | +1.14% | Acquired | 78.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 8, 2017 | DBD | Non-Qualified Stock Options [F3] | Common Shares (200,000) | $26.60 | Feb. 7, 2027 | 200,000 | Acquired |
| Feb. 3, 2016 | DBD | Non-Qualified Stock Option [F3] | Common Shares (200,000) | $27.39 | Feb. 3, 2026 | 200,000 | Acquired |
| Feb. 5, 2015 | DBD | Non-Qualified Stock Option [F3] | Common Shares (200,000) | $32.33 | Feb. 5, 2025 | 200,000 | Acquired |
| Feb. 12, 2014 | DBD | Non-Qualified Stock Option [F3] | Common Stock (154,766) | $34.13 | Feb. 12, 2024 | 154,766 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 2, 2022 | COHU | No securities are beneficially owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | — | — | — | — | $585,000 | — | $190,458 | $5,966,752 |
| 2013 | $408,365 | — | — | — | $529,973 | — | $95,732 | $4,323,062 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.